Target intelligence / Profile preview

RNA, U6 small nuclear 1006, pseudogene (RNU6-1006P)

Target
RNU6-1006P
Molecular classification
Other (pseudogene), Non-coding RNA pseudogene
01

Overview

RNU6-1006P is a pseudogene copying part of the U6 small nuclear RNA (snRNA) gene. The U6 snRNA itself is a critical, highly conserved component of the spliceosome that catalyzes intron removal from precursor mRNA in the nucleus[1][3][11]. However, as a pseudogene, RNU6-1006P does not produce a functional transcript[5][7]. Like other pseudogenes, segments of its sequence are homologous to its parent gene, but it carries disabling mutations or is not expressed as a functional RNA[4][5]. Genomic studies have shown many U6-related pseudogenes in the human genome, likely resulting from retrotransposition or duplication events[3][7]. While most pseudogenes were historically considered non-functional, some have been found to exert regulatory effects via interactions with RNAs or chromatin, such as miRNA sponging or producing small RNAs, but there is no evidence that RNU6-1006P plays any such specific roles[4][6]. Summary: RNU6-1006P is a non-functional pseudogene, homologous to U6 small nuclear RNA, with no evidence of therapeutic, biomarker, or disease relevance, and should not be considered a receptor or molecular drug target[5][4][3].

Other names
RNU6-1006PRNA, U6 small nuclear 1006, pseudogene
02

Biological functions

Genomic element with sequence homology to U6 small nuclear RNA geneNo direct function as an RNA or protein; below mechanisms pertain to pseudogenes in general
03

Disease associations

Other (pseudogenes in general may play roles in gene regulation, but no disease association is established for RNU6-1006P specifically)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1006, pseudogene (RNU6-1006P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1006, pseudogene (RNU6-1006P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call